abstract |
The present invention provides human receptors (REPTRs) and polynucleotides that identify and encode REPTRs. The present invention also provides expression vectors, host cells, antibodies, agonists and antagonists. The present invention also provides a method for diagnosing, treating or preventing a disease associated with abnormal expression of REPTR. |